Novo Nordisk to Use Linguamatics Text Mining Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Linguamatics today said that the diabetes care company Novo Nordisk will use its text mining and natural language processing software.

Under a multi-year agreement, the Cambridge, UK-based company said that Novo Nordisk will use its I2E to mine published literature and internal information sources to provide intelligence for making research and development decisions. Linguamatics COO Roger Hale said in a statement that the I2E platform can be used to "deliver value for questions ranging from R&D to business and competitor intelligence."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.